{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:24:26Z","timestamp":1791321866152,"version":"4.3.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1067\/mjd.2001.116345","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T18:14:26Z","timestamp":1030212866000},"page":"208-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Complete molecular remission during biologic response modifier therapy for S\u00e9zary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity"],"prefix":"10.1067","volume":"45","author":[{"given":"Elisa K.","family":"Yoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Cassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart R.","family":"Lessin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain H.","family":"Rook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2001.116345_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-3-642-78771-3_17","article-title":"New perspectives in experimental and clinical research for cutaneous T cell lymphomas","volume":"139","author":"Burg","year":"1995","journal-title":"Recent Results Cancer Res"},{"key":"10.1067\/mjd.2001.116345_bib2","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0889-8588(18)30054-6","article-title":"The immunopathogenesis of cutaneous T-cell lymphoma","volume":"9","author":"Rook","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1067\/mjd.2001.116345_bib3","doi-asserted-by":"crossref","first-page":"534","DOI":"10.7326\/0003-4819-83-4-534","article-title":"Cutaneous T-cell lymphomas: the S\u00e9zary syndrome, mycosis fungoides and related disorders","volume":"83","author":"Lutzner","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1067\/mjd.2001.116345_bib4","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJM198105283042202","article-title":"Phenotypic characterization of cutaneous T-cell lymphoma","volume":"304","author":"Haynes","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2001.116345_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0190-9622(80)80385-9","article-title":"Cutaneous T cell lymphoma: mycosis fungoides, S\u00e9zary syndrome, and other variants","volume":"2","author":"Edelson","year":"1980","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.116345_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0190-9622(90)70054-L","article-title":"S\u00e9zary syndrome: diagnosis, prognosis, and critical review of treatment options","volume":"22","author":"Wieselthier","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.116345_bib7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.7326\/0003-4819-109-5-372","article-title":"Histopathologic staging at initial diagnosis of mycosis fungoides and the S\u00e9zary syndrome","volume":"109","author":"Sausville","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1067\/mjd.2001.116345_bib8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0190-9622(97)70212-3","article-title":"Prognostic factors and evaluation of mycosis fungoides and S\u00e9zary syndrome","volume":"37","author":"Toro","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.116345_bib9","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archderm.1995.01690210033005","article-title":"Prognostic factors in erythrodermic mycosis fungoides and the S\u00e9zary syndrome","volume":"131","author":"Kim","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.116345_bib10","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archderm.1993.01680250098016","article-title":"The immunopathogenesis of cutaneous T-cell lymphoma: abnormal cytokine production by S\u00e9zary T cells","volume":"129","author":"Rook","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.116345_bib11","first-page":"4430","article-title":"Abnormal cytokine expression in S\u00e9zary syndrome and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies","volume":"54","author":"Tendler","year":"1994","journal-title":"Cancer Res"},{"key":"10.1067\/mjd.2001.116345_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/1523-1747.ep12611877","article-title":"Aberrant cytokine production by S\u00e9zary syndrome patients: cytokine secretion pattern resembles murine Th2 cells","volume":"99","author":"Vowels","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2001.116345_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1523-1747.ep12388985","article-title":"Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas S\u00e9zary syndrome expresses a Th2-type profile","volume":"103","author":"Saed","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2001.116345_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/archderm.1993.01680250045005","article-title":"Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma","volume":"129","author":"Dummer","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.116345_bib15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1523-1747.ep12398454","article-title":"Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma","volume":"103","author":"Vowels","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2001.116345_bib16","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1200\/JCO.1995.13.7.1751","article-title":"Large cell transformation following detection of minimal residual disease in cutaneous T-cell lymphoma: molecular and in-situ analysis of a single neoplastic T-cell clone expressing the identical T-cell receptor","volume":"13","author":"Wolfe","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1067\/mjd.2001.116345_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/1523-1747.ep12389114","article-title":"Detection of clonal T-cell receptor g gene rearrangements in early mycosis fungoides\/S\u00e9zary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR\/DGGE)","volume":"103","author":"Wood","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2001.116345_bib18","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0889-8588(18)30057-1","article-title":"Topical treatment of early cutaneous T-cell lymphoma","volume":"9","author":"Ramsay","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1067\/mjd.2001.116345_bib19","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0889-8588(18)30058-3","article-title":"Electron beam treatment for cutaneous T-cell lymphoma","volume":"9","author":"Jones","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1067\/mjd.2001.116345_bib20","first-page":"382","article-title":"Therapy with OKT3 monoclonal antibody in refractory T cell acute lymphoblastic leukemia induces interleukin-2 responsiveness","volume":"9","author":"Gramatzki","year":"1995","journal-title":"Leukemia"},{"key":"10.1067\/mjd.2001.116345_bib21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0733-8635(18)30272-9","article-title":"Therapeutic applications of photopheresis","volume":"11","author":"Rook","year":"1993","journal-title":"Dermatol Clin"},{"key":"10.1067\/mjd.2001.116345_bib22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM198702053160603","article-title":"Treatment of cutaneous T cell lymphoma by extracorporeal photochemotherapy: preliminary results","volume":"316","author":"Edelson","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2001.116345_bib23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0190-9622(92)70212-X","article-title":"Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy","volume":"27","author":"Heald","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.116345_bib24","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0190-9622(96)90119-X","article-title":"Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution","volume":"35","author":"Gottlieb","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.116345_bib25","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0889-8588(18)30060-1","article-title":"Interferon in the treatment of cutaneous T-cell lymphoma","volume":"9","author":"Olsen","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1067\/mjd.2001.116345_bib26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0190-9622(89)70049-9","article-title":"Interferon alfa-2a in the treatment of cutaneous T cell lymphoma","volume":"20","author":"Olsen","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.116345_bib27","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1001\/archderm.1991.01680090099012","article-title":"Combined therapy for S\u00e9zary syndrome with extracorporeal photochemotherapy and low-dose interferon alfa therapy","volume":"127","author":"Rook","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.116345_bib28","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V88.4.1383.bloodjournal8841383","article-title":"S\u00e9zary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-\u03b3 receptor \u03b2-chain)","volume":"88","author":"Dummer","year":"1996","journal-title":"Blood"},{"key":"10.1067\/mjd.2001.116345_bib29","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1084\/jem.170.5.1751","article-title":"Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells","volume":"170","author":"Peleman","year":"1989","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2001.116345_bib30","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0190-9622(95)90067-5","article-title":"CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides","volume":"32","author":"Hoppe","year":"1995","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1067\/mjd.2001.116345_bib31","doi-asserted-by":"crossref","first-page":"105S","DOI":"10.1038\/jid.1995.21","article-title":"Lymphocyte activation in cutaneous T-cell lymphoma","volume":"105","author":"Wood","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2001.116345_bib32","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/1523-1747.ep12363378","article-title":"The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens","volume":"107","author":"Berger","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2001.116345_bib33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1600-0560.1994.tb00250.x","article-title":"Mycosis fungoides skin lesions contain CD8+ tumor-infiltrating lymphocytes expressing an activated, MHC-restricted cytotoxic T-lymphocyte phenotype","volume":"21","author":"Wood","year":"1994","journal-title":"J Cutan Pathol"},{"key":"10.1067\/mjd.2001.116345_bib34","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.4049\/jimmunol.140.12.4245","article-title":"Anti-proliferative effect of IFNg in immune regulation: IFNg inhibits the proliferation of TH2 but not TH1 murine CTL clones","volume":"140","author":"Gajweski","year":"1988","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2001.116345_bib35","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1084\/jem.178.5.1655","article-title":"Interferon a increases the frequency of interferon \u03b3-producing human CD4+ T cells","volume":"178","author":"Brinkmann","year":"1993","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2001.116345_bib36","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4049\/jimmunol.154.3.1491","article-title":"IL-12 reverses cytokine and immune abnormalities in S\u00e9zary syndrome","volume":"154","author":"Rook","year":"1995","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2001.116345_bib37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-3083.1994.tb03441.x","article-title":"Immunoregulatory effects of cytokines on natural killer cells","volume":"40","author":"Naume","year":"1994","journal-title":"Scand J Immunol"},{"key":"10.1067\/mjd.2001.116345_bib38","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00001622-199803000-00015","article-title":"Use of biological response modifiers in the treatment of cutaneous T-cell lymphoma","volume":"10","author":"Rook","year":"1998","journal-title":"Curr Opin Oncol"},{"key":"10.1067\/mjd.2001.116345_bib39","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1084\/jem.177.4.1199","article-title":"Natural killer cell stimulatory factor (Interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells","volume":"177","author":"Manetti","year":"1993","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2001.116345_bib40","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1084\/jem.178.4.1223","article-title":"Antitumor and antimetastatic activity of interleukin 12 against murine tumors","volume":"178","author":"Brunda","year":"1993","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2001.116345_bib41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0008-8749(92)90011-D","article-title":"Regulation of human cytolytic lymphocyte responses by interleukin-12","volume":"143","author":"Gately","year":"1992","journal-title":"Cell Immunol"},{"key":"10.1067\/mjd.2001.116345_bib42","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood.V94.3.902.415k23_902_908","article-title":"Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses","volume":"94","author":"Rook","year":"1999","journal-title":"Blood"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962201252992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962201252992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:25:19Z","timestamp":1759267519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962201252992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["S0190962201252992"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2001.116345","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complete molecular remission during biologic response modifier therapy for S\u00e9zary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1067\/mjd.2001.116345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}